The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Randomised controlled trials and other prospective clinical studies for novel medical
interventions in people with diabetes have traditionally reported HbA 1c as the measure of …

Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

Objective To provide evidence-based recommendations regarding the use of advanced
technology in the management of persons with diabetes mellitus to clinicians, diabetes-care …

Improvements in sensor accuracy, greater convenience and ease of use, and expanding
reimbursement have led to growing adoption of continuous glucose monitoring (CGM) …

Importance Continuous glucose monitoring (CGM) provides real-time assessment of
glucose levels and may be beneficial in reducing hypoglycemia in older adults with type 1 …

Background: There has been recent recognition of the limitations of hemoglobin A1C
(HbA1C) in describing both short-and long-term glycemic control. Continuous glucose …

The American Diabetes Association (ADA)“Standards of Medical Care in Diabetes” includes
ADA's current clinical practice recommendations and is intended to provide the components …

Background: As the use of continuous glucose monitoring (CGM) increases, there is a need
to better understand key metrics of time in range 70-180 mg/dL (TIR70-180) and …

Background: A composite metric for the quality of glycemia from continuous glucose monitor
(CGM) tracings could be useful for assisting with basic clinical interpretation of CGM data …